100% Quality Guarantee
PhD-Level Technical Support
Key Features

Human APLNR (Apelin Receptor) ELISA Kit (AEKE02696)

SKU AEKE02696
Size 96 Assays
Reactivity Human
Assay Type Sandwich
Sensitivity 6.5 pg/mL
Range 15.63-1000 pg/mL
Standard 1000 pg/mL
$857 - $7,710

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

Human APLNR ELISA Kit

Human APLNR ELISA kits are used to detect Apelin Receptor (APLNR) in tissue homogenates and other biological samples. APLNR (apelin receptor, also called APJ or angiotensin receptor-like 1) is a G protein-coupled receptor that binds the peptide hormones apelin and ELA (also known as apela or toddler), and it is expressed in heart, vasculature, brain, kidney and adipose tissue. Activation couples to Gi proteins, inhibiting adenylate cyclase, and also engages the beta-arrestin pathway, which promotes receptor internalisation. The apelin-APLNR axis regulates cardiovascular function, including cardiac contractility and vasodilation, as well as fluid homeostasis, angiogenesis and energy metabolism. It is essential for early cardiovascular development. Reduced signalling has been associated with heart failure and hypertension, and the receptor is a drug target. It is also studied in obesity, diabetes and tumour angiogenesis.

system_update_altDatasheetsystem_update_altMSDS
View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose